InBio offers a range of custom viral testing services, in our tissue culture facilities that operate up to Biosafety Level 2, focused on early stage product R&D.
- Assessment of virus viability on surfaces, including testing for SARS-CoV-2 (using Vaccinia virus or representative human coronaviruses)*
- Product efficacy testing to measure virucidal effects of disinfectants & cleaning products
- Suspension or surface testing
Custom methods.
InBio scientists with expertise in viral immunology can work with you to develop custom testing methods for your specific applications.
Watch and learn more about InBio’s Viral Testing capabilities.
*A note on SARS-CoV-2
In accordance with EN 14476 standards, products shown to be effective against Vaccinia virus can be deemed effective against all enveloped viruses, including coronaviruses.
Human Coronavirus 229E can also be used as surrogates for SARS-CoV-2.
InBio provides testing with these viruses to support virucidal efficacy claims against coronaviruses, including SARS-CoV-2.
